Targeting the neuromuscular junction in skeletal muscles.
Childers
Martin K
MK
Department of Physical Medicine and Rehabilitation, School of Medicine, University of Missouri-Columbia, Columbia, Missouri 65212, USA.
D000818:Animals; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D006801:Humans; D007273:Injections, Intramuscular / Q000379:methods; D023421:Models, Animal; D009069:Movement Disorders / Q000188:drug therapy / Q000503:physiopathology; D018482:Muscle, Skeletal / Q000294:innervation* / Q000502:physiology; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D009469:Neuromuscular Junction / Q000502:physiology*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A